Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
19 02 2019
Historique:
received: 06 09 2018
revised: 31 10 2018
accepted: 31 10 2018
entrez: 16 2 2019
pubmed: 16 2 2019
medline: 23 1 2020
Statut: ppublish

Résumé

Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a widely used form of mechanical circulatory support in patients with refractory cardiogenic shock. A common drawback of this modality is a resultant increase in left ventricular afterload. The purpose of this meta-analysis was to examine the efficacy and safety of left ventricular unloading strategies during VA-ECMO in adult patients with cardiogenic shock. The authors performed a systematic search of studies examining left ventricular unloading during VA-ECMO in Medline, EMBASE, and the Cochrane library. The primary outcome was all-cause mortality. Secondary outcomes included limb ischemia, bleeding, need for renal replacement therapy, multiorgan failure, stroke or transient ischemic attack, and hemolysis. Of 2,221 publications identified, 17 observational studies met the inclusion criteria. In total, outcomes in 3,997 patients were included with 1,696 (42%) receiving a concomitant left ventricular unloading strategy while on VA-ECMO (intra-aortic balloon pump 91.7%, percutaneous ventricular assist device 5.5%, pulmonary vein or transseptal left atrial cannulation 2.8%). There were 2,412 deaths (60%) in the total cohort. Mortality was lower in patients with (54%) versus without (65%) left ventricular unloading while on VA-ECMO (risk ratio: 0.79; 95% confidence interval: 0.72 to 0.87; p < 0.00001). Hemolysis was higher in patients who underwent VA-ECMO with left ventricular unloading. Otherwise, secondary outcomes were not demonstrably different in patients treated with VA-ECMO with versus without left ventricular unloading. In observational studies, left ventricular unloading was associated with decreased mortality in adult patients with cardiogenic shock treated with VA-ECMO. In the absence of prospective randomized data, left ventricular unloading may be considered for appropriately selected patients undergoing VA-ECMO support.

Sections du résumé

BACKGROUND
Venoarterial extracorporeal membrane oxygenation (VA-ECMO) is a widely used form of mechanical circulatory support in patients with refractory cardiogenic shock. A common drawback of this modality is a resultant increase in left ventricular afterload.
OBJECTIVES
The purpose of this meta-analysis was to examine the efficacy and safety of left ventricular unloading strategies during VA-ECMO in adult patients with cardiogenic shock.
METHODS
The authors performed a systematic search of studies examining left ventricular unloading during VA-ECMO in Medline, EMBASE, and the Cochrane library. The primary outcome was all-cause mortality. Secondary outcomes included limb ischemia, bleeding, need for renal replacement therapy, multiorgan failure, stroke or transient ischemic attack, and hemolysis.
RESULTS
Of 2,221 publications identified, 17 observational studies met the inclusion criteria. In total, outcomes in 3,997 patients were included with 1,696 (42%) receiving a concomitant left ventricular unloading strategy while on VA-ECMO (intra-aortic balloon pump 91.7%, percutaneous ventricular assist device 5.5%, pulmonary vein or transseptal left atrial cannulation 2.8%). There were 2,412 deaths (60%) in the total cohort. Mortality was lower in patients with (54%) versus without (65%) left ventricular unloading while on VA-ECMO (risk ratio: 0.79; 95% confidence interval: 0.72 to 0.87; p < 0.00001). Hemolysis was higher in patients who underwent VA-ECMO with left ventricular unloading. Otherwise, secondary outcomes were not demonstrably different in patients treated with VA-ECMO with versus without left ventricular unloading.
CONCLUSIONS
In observational studies, left ventricular unloading was associated with decreased mortality in adult patients with cardiogenic shock treated with VA-ECMO. In the absence of prospective randomized data, left ventricular unloading may be considered for appropriately selected patients undergoing VA-ECMO support.

Identifiants

pubmed: 30765031
pii: S0735-1097(18)39445-2
doi: 10.1016/j.jacc.2018.10.085
pii:
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

654-662

Subventions

Organisme : NCATS NIH HHS
ID : KL2 TR001874
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Juan J Russo (JJ)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Natasha Aleksova (N)

Toronto General Hospital, Toronto, Ontario, Canada.

Ian Pitcher (I)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Etienne Couture (E)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Simon Parlow (S)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Mohammad Faraz (M)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Sarah Visintini (S)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Trevor Simard (T)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Pietro Di Santo (P)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Rebecca Mathew (R)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Derek Y So (DY)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Koji Takeda (K)

Columbia University Medical Center, New York, New York.

A Reshad Garan (AR)

Columbia University Medical Center, New York, New York.

Dimitrios Karmpaliotis (D)

Columbia University Medical Center, New York, New York.

Hiroo Takayama (H)

Columbia University Medical Center, New York, New York.

Ajay J Kirtane (AJ)

Columbia University Medical Center, New York, New York.

Benjamin Hibbert (B)

University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: bhibbert@ottawaheart.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH